The Uromigos Episode 18: COVID-19—Addressing Renal Cancer Patients’ Concerns

Dena Battle, president of KCCure, presents a survey of over 500 patients from 16 different countries on issues around COVID-19 and kidney cancer treatment. The results showed that the pandemic is causing high levels of anxiety among patients with kidney cancer and that 70% of these patients believed they were at a higher risk of COVID-19 infection. Drs. Tom Powles and Brian Rini weigh in on the issues raised in these findings.

Related Episodes

The Uromigos Episode 155: ASCO GU 2022 ARASENS Trial of Darolutamide and Chemo Versus Chemo Alone in Hormone Sensitive Advanced Prostate Cancer
The Uromigos Episode 135: The STAR Study
The Uromigos Episode 9: COVID-19 and Cancer—An International Perspective
The Uromigos Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
The Uromigos Episode 12: COVID-19 in Cancer Patients—The Seattle Experience
The Uromigos Episode 8: COVID-19 and Cancer Patients
The Uromigos Episode 10: COVID-19 and Renal Cancer—A Patient’s Perspective
The Uromigos Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
The Uromigos Episode 17: Dr. Toni Choueiri Discusses Cancer Trials and Meetings During COVID-19
The Uromigos Episode 16: Treatments and Trials for COVID-19